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allylation procedure employing allene and  a catalytic Pd/In bimetallic process   © 2008 Elsevier Science. All rights reserved 
——— 
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Introduction 
 
While α-amino acids are essential prerequisites for 
life, the β-amino isomers are far less common in living 
organisms. However, they are constituents of wide variety 
of natural products and various polypeptides with different 
biological properties1 and have attracted growing interest.2 
These polypeptides have been shown to form secondary 
structures analogous to those of natural polypeptides, but 
are metabolically more stable than the α-amino acid 
equivalents.3 This is particularly interesting from a 
medicinal chemistry point of view. Due to the increased 
interest in this area, β-amino acids have emerged as 
important synthetic targets and a range of methodologies 
have been developed for their preparation. The majority of 
these procedures are based on either the Mannich4a-d or  
aza-Michael4e-g  reactions, although others methods are also 
known.4h-j  
 
Results and Discussion 
Our approach to the synthesis of β-amino acids is 
based on our Pd/In transmetallation process5 involving 
allenes as key reactants. This methodology possesses 
significant synthetic diversity advantages in allowing 
access to a wide range of 2- and 2, 3-disubstituted allylic 
species. Others have developed analogous processes 
involving allylic acetates.6 In recent years, the potential of 
this umpolung procedure, in which a nucleophilic In-
species is generated from an electrophilic Pd-species, has 
been exemplified by the synthesis of a range of 
compounds,7 including chiral non-natural α-amino acids.8  
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Our strategy for the stereoselective synthesis of β-amino 
acid derivatives using our methodology is outlined in 
Scheme 1. The oxidative addition of the aryl iodide 1 to 
Pd(0) followed by reaction with allene 2 is expected to 
generate an allyl-Pd(II) species a which would then create a 
nucleophilic allyl-In species b, via a redox transmetallation 
process. Reaction of intermediate b with sulfinimine 3 
would then afford the product. It was envisaged that the 
stereoselectivity of this process would be controlled by the 
chiral sulfinimine, which has been shown to be an efficient 
auxiliary in related transformations.8,9 Although the cascade 
could afford two regioisomeric products, 4 and 5, 
stereoelectronic factors were expected  to control  the 
regiochemistry leading to 4 as the  sole or  major product. 
Overall, this three component coupling would create two 
new bonds and two chiral centres.   
In the event stirring and heating iodobenzene, 
allene 6 and imine (S)-7 in DMF in the presence of 
Pd(OAc)2, tri-2-furyl phosphine, In and additives10 in a 
Schlenk flask at 40 0C afforded the expected product as a 
15:1 mixture of separable diastereoisomers, 8 and 9, in 
69% yield (Scheme 2a, Table 1, entry 1). To our delight the 
regioisomeric product 5 (Scheme 1) was not observed. 
When the reaction was carried out using the 
enantiomeric sulfinimine, (R)-7 the results were identical 
apart from the sense of chiral induction (entry 1 vs entry 2, 
Table 1). Additional examples, performed with both 
enantiomeric sulfinimines 7 and 4-methyl- or 4-
phenyliodobenzene, under the same conditions, afforded 
analogous products in good yield and with a high degree of 
diastereoselectivity, Table 1. Although the para substituent 
on the aryl iodide seems to influence the 
diastereoselectivity, the origin of this effect is not at present 
clear.  It has been previously shown that the sulfoxy group 
can be easily removed8,9 from N-atom. Hence, the process 
depicted by Scheme 2 is an efficient way to synthesise 
certain classes of β2,3-disubstituted-β-amino acids.  
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Table 1 Synthesis of chiral β-amino acid derivativesa
Entry Ar(I) Imine  Ratio 8:9b Yield 
(%)c
1  
 
S  15(S,S,S): 1(S,S,R) 60 
2  R 15(R,R,R):1(R,R,S) 60 
3  S 
 
 9(S,S,S):1(S,S,R) 60 
4  
 
R  19(R,R,R):1(R,R,S) 60 
5  
 
 
S  12(S,S,S):1(S,S,R) 69 
6  
 
 
R 12(R,R,R):1(R,R,S) 62 
a Reaction conditions: ArI (0.75 mmol), iminoester (0.5 mmol), allene 
(0.75 mmol), Pd(OAc)2   (0.05 mmol), phosphine (0.1 mmol), In (0.75 
mmol), CuI (0.1 mmol), ascorbic acid   (0.2 mmol), DMF (10 mL) in a  
Schlenk flask, 40 oC, 24 h. 
 b Calculated by integration of the 1H NMR spectra of the product mixtures 
 c Isolated yield 
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The absolute stereochemistries of the major 
products, 8e and 8f, were established by X-ray 
crystallography (Figure 1). These data demonstrate that 
(S)-7 and (R)-7 engender S- and R- stereochemistry on both 
newly formed chiral centres respectively.  
 
 
 
 
 
 
 
 
 
 
 
     (S,S,S)-8e 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 R,R,R)-8f 
 
Figure 1 
 
 
Based on the absolute stereochemistry of the products and 
our           previous semi-empirical calculations using 
MOPAC v7 of related reactions forming α-amino acids,7 
the transition state leading to the major product was 
proposed (Figure 2). Compound 8e is formed via a 
Zimmerman-Traxler chair - like transition state A, 
involving an  In(I) species,11 an E-allylindium species and 
addition to the Si face of the  sulfinimine. This transition 
state may be further stabilised by the proximity of 
heteroatoms in the sulfinimine moieties and their ability to 
coordinate indium. An additional stabilisation factor is the 
potential π -π interactions between the electron deficient 2-
pyridyl substituent and the electron rich aromatic 
substituents. The enantiomeric product 8f is proposed to 
form via transition state B involving the Z-allylindium 
species. Although this transition state seems to be more 
stable due to pseudoequatorial orientation of the ester 
moiety, Z- and E-η1-allylindium species are not expected to 
interconvert under these conditions12 and their ratio is thus 
thought to reflect the ratio of the syn- and anti--
allylpalladium(II) intermediates trapped out by indium. 
This would accord with our previous experience involving 
π−allylpalladium species from monosubstituted allenes 
where  the 1,2-disubstituted- E- isomer is the predominent 
or sole species. This in turn would indicate that transfer of 
the allyl moiety from palladium to indium occurs with 
retention of alkene geometry. 
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 Tetrahedron 4 
The mechanism of the reductive transmetallation  proceeds 
via Pd-In bond formation or a pd-X-In bridged species13 
resulting in the delivery of indium to the same face of the 
allyl system as palladium. There is literature precedent for 
this in the both indium and zinc transmetallation with π - 
allyl Pd(II).14  
An unresolved problem is that if indeed indium(I) allyl is 
the key allylation agent then two equivalents of In(0) are 
required for the reduction of Pd(II) and the nature of this 
process is unclear.15 However, we employed only 1.5 mole 
equiv of  In and yields/conversion were depressed in the 
absence of CuI8 and ascorbic acid.  
We believe a key role of the CuI additive is to promote 
formation of InI and hence facilitate transfer of indium 
from the solid to the solution phase. The formation of 
copper allyl species16 may also be involved. The ascorbic 
acid was added  to help recycle unproductive higher 
valency states of the Pd, Cu,17 and In if present. It is 
undoubtedly benefical but its precise role(s) is unclear. 
In conclusion, a short, diastereoselective synthesis of  
β2,3-disubstituted-β−amino acid derivatives has been 
developed, employing Pd/In transmetallation processes. 
Under very mild conditions the three component coupling, 
forming two bonds and two chiral centres, afforded the 
products in good yield and with a high degree of 
diastereoselectivity. Further study of this process is 
underway.                        
 
Experimental 
Unless otherwise noted all reagents were obtained from 
commercial suppliers and used without further purification. 
All solvents were dried or purified by literature 
procedures.18 Chromatography columns were prepared 
using Fisher chemicals 60A 35 – 70 micron silica gel. 
Nuclear magnetic resonance spectra were recorded using 
Bruker DPX300 and DRX500 MHz spectrometers. 
Chemical shifts are reported in parts per million (δ) 
downfield relative to the internal reference 
tetramethylsilane. Unless otherwise specified NMR spectra 
were recorded in deuterochloroform at room temperature. 
Abbreviations used; Ar = aromatic, d = doublet, dd = 
doublet of doublets, dq = doublet of quartets, dt = doublet 
of triplets, m = multiplet, q = quartet, s = singlet, t = triplet. 
Mass spectra were recorded using a micromass ZMD 2000 
spectrometer employing the electrospray (ES+) ionisation 
technique. Accurate molecular masses were obtained from 
the EPSRC Swansea Mass Spectroscopy service using 
perfluorotributylamine or polyethylenimine as an internal 
standard. Infra-red spectra were recorded using a Perkin-
Elmer FT-IR spectrometer.  IR spectra of liquids were 
recorded as thin films on sodium chloride plates. IR spectra 
of solids were recorded using the “golden gate” apparatus.  
Optical rotations were measured on an Optical Activity 
AA-1000 polarimeter. Rotations are quoted in 10-1 deg cm2 
g-1 and the concentration (c) is expressed in g per 100 mL. 
Unless otherwise stated chloroform was the solvent. 
Microanalysis was performed using a Carlo-Erber 1108 
elemental analyser and, for sulfur, by titration against 
barium perchlorate 
General procedure for the synthesis of β-amino acid 
derivatives 
Aryl iodide 1 (0.75 mmol) was added to a suspension of 
chiral sulfinimine 7  (0.5 mmol), ethyl 2,3-butadienoate 6 
(0.75 mmol), indium metal powder (0.088 g, 0.75 mmol), 
Pd(OAc)2 (0.011g, 0.05 mmol), tri-2-furyl phosphine  
(0.024 g, 0.1 mmol), CuI (0.019 g, 0.1 mmol) and ascorbic 
acid (0.0355 g, 0.2 mmol) in  DMF (10 mL) in a Schlenk 
tube. The flask was flushed with nitrogen and sealed. The 
mixture was stirred and heated to 40 oC (oil bath 
temperature) for 24 h, left to cool and vented. Ethyl acetate 
(20 mL) and 5 % HCl aqueous solution (10 mL) were 
added and the mixture stirred for 20 min. The phases were 
separated and the aqueous layer extracted with ethyl acetate 
(20 mL). The organic extracts were combined and washed 
with water (3 x 40 mL), dried (MgSO4), filtered and the 
filtrate concentrated in vacuo.  
The residue was purified by flash chromatography to give 
the N – sulfinyl - β - amino ester. 
Ethyl (S,S,S) 2-[(2-methyl-propane-2-sulfinylamino)-
pyridin-2-yl-methyl]-3-phenyl-but-3-enoate (S,S,S)-8a 
N
H
S+
O-
CO2Et
N
H
..
2
3
4
5
6
34
5
6
a
Hb
 
Obtained as a pale yellow oil (0.120 g, 60 %) after flash 
chromatography (EtOAc); RF; 0.38 (EtOAc); – 14.4 
(c 1.4); Found; C, 66.10; H, 7.30; N, 7.10; S, 7.80, 
C
20][ Da
22H28N2O3S requires; C, 65.97; H, 7.05; N, 6.99; S, 8.01 
%; νmax/cm-1; 3453, 3254 (NH), 3063, 2947, 2321, 2219, 
2136, 1954, 1832, 1732 (CO); δH (500 MHz, CDCl3); 8.54 
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(1H, d, pyridyl-6H, J =  4.7 Hz), 7.61 (1H, t, Ar-4H, J =  
7.7 Hz), 7.48 (1H, d, pyridyl-3H, J =  7.3 Hz), 7.42 (2H, d, 
Ar-2H, Ar-6H, J = 7.7 Hz), 7.34 (2H, t, Ar-3H, Ar-5H, J =  
7.7 Hz), 7.28 (1H, t, pyridyl-4H, J = 7.3 Hz), 7.16 (1H, dd, 
pyridyl-5H, J = 4.7, 7.3 Hz), 5.63 (1H, s, =CHa), 5.56 (1H, 
s, =CHb), 4.97 (1H, t, NCH, J = 9.8 Hz), 4.41 (1H, d, NH, 
J = 9.8 Hz), 4.25 (1H, d, NCHCH, J = 9.8 Hz), 3.98 – 3.92 
(2H, m, OCH2), 1.06 (9H, s, C(CH3)3), 1.02 (3H, t, 
OCH2CH3, J = 7.3 Hz); δc (75 MHz, CDCl3); 172.0 (CO), 
160.3 (=C), 149.6 (Ar), 144.3 (Ar), 142.0 (Ar), 137.0 (Ar), 
128.7 (Ar), 128.1 (Ar), 126.8 (Ar),126.7 (Ar), 124.1 (Ar), 
123.2 (Ar), 117.2 (=CH2), 63.7 (NC), 61.2 (OC), 56.6 (SC), 
56.4 (NCC), 22.8 (C(CH3)3), 14.2 (OCC); m/z (ES+); 401 
(MH+). 
Ethyl (R,R,R) 2-[(2-methyl-propane-2-sulfinylamino)-
pyridin-2-yl-methyl]-3-phenyl-but-3-enoate (R,R,R)-8b 
 
 
 
 
 
 
 
 
 
 
 
Obtained as a pale yellow oil (0.120 g, 60 %) after flash 
chromatography (EtOAc); RF; 0.38 (EtOAc); 
20][ Da  + 12.8 
(c 1.9); Found; C, 66.10; H, 7.10; N, 7.20; S, 8.0, 
C22H28N2O3S requires; C, 65.97; H, 7.05; N, 6.99; S, 8.01 
%; νmax/cm-1; 3451, 3248 (NH), 3066, 2953, 2325, 2216, 
2141, 1954, 1832, 1732 (CO); δH (500 MHz, CDCl3); 8.54 
(1H, d, pyridyl-6H, J = 4.7 Hz), 7.61 (1H, t, Ar-4H, J = 7.7 
Hz), 7.48 (1H, d, pyridyl-3H, J = 7.3 Hz), 7.42 (2H, d, Ar-
2H, Ar-6H, J = 7.7 Hz), 7.34 (2H, t, Ar-3H, Ar-5H, J = 7.7 
Hz), 7.28 (1H, t, pyridyl-4H, J = 7.3 Hz), 7.16 (1H, dd, 
pyridyl-5H, 4.7, 7.3 Hz), 5.63 (1H, s, =CHa), 5.56 (1H, s, 
=CHb), 4.97 (1H, t, NCH, J = 9.8 Hz), 4.41 (1H, d, NH, J 
= 9.8 Hz), 4.25 (1H, d, NCHCH, J = 9.8 Hz), 3.98 – 3.92 
(2H, m, OCH2), 1.06 (9H, s, C(CH3)3), 1.02 (3H, t, 
OCH2CH3, J = 7.3 Hz), δc (75 MHz, CDCl3); 172.0 (CO), 
160.3 (=C), 149.8 (Ar), 144.3 (Ar), 142.0 (Ar), 137.1 (Ar), 
128.7 (Ar), 128.1 (Ar), 126.9 (Ar), 126.7 (Ar), 124.1 (Ar), 
123.3 (Ar), 117.3 (=CH2), 63.9 (NC), 61.2 (OC), 56.7 (SC), 
56.4 (NCC), 23.0 (C(CH3)3), 14.3 (OCC); m/z (ES+); 401 
(MH+). 
Ethyl (S,S,S) 2-[(2-methyl-propane-2-sulfinylamino)-
pyridin-2-yl-methyl]-3-p-tolyl-but-3-enoate (S,S,S)-8c 
N
H
S
+
O
CO2Et
N
..
34
5
6
2
35
6
 
Obtained as colourless prisms (0.088 g, 60 %), mp 74-76 
oC after flash chromatography (EtOAc); RF; 0.40 (EtOAc); 
– 20.3 (c 1.1); Found; 415.2069; C20][ Da 23H30N2O3S 
requires 415.2055; νmax/cm-1; 3254 (NH), 3181, 3056, 2411, 
2219, 2047, 1922, 1821, 1738 (CO); δH (500 MHz, CDCl3); 
8.54 (1H, d, pyridyl-6H, J = 4.5 Hz), 7.61 (1H, td, pyridyl-
4H, J = 1.7, 7.7 Hz), 7.42 (1H, d, pyridyl-3H, J = 7.7 Hz), 
7.38 (2H, d, Ar-3H, Ar-5H, J = 8.1 Hz), 7.15 (3H, m, Ar-
2H, Ar-6H, pyridyl-5H), 5.59 (1H, s, =CHa), 5.51 (1H, s, 
=CHb), 4.95 (1H, t, NCH, J = 9.4 Hz), 4.40 (1H, d, NH, J 
= 9.4 Hz), 4.23 (1H, d, NCHCH, J = 9.4 Hz), 3.97 – 3.90 
(2H, m, OCH2), 1.06 (9H, s, C(CH3)3), 1.01 (3H, t, 
OCH2CH3, J = 7.3 Hz), δc (75 MHz, CDCl3); 172.1 (CO), 
160.3 (=C), 149.8 (Ar), 144.1 (Ar), 139.1 (Ar), 137.9 (Ar), 
137.0 (Ar), 129.4 (Ar), 126.7 (Ar), 123.9 (Ar), 123.2 (Ar), 
116.1 (=CH2), 63.9 (NC), 61.2 (OC), 56.7 (SC), 56.4 
(NCC), 23.0 (C(CH3)3), 21.5 (ArCH3), 14.3 (OCH2CH3); 
m/z (ES+); 415 (MH+). 
N
H
S+
O-
CO2Et
N
H ..
2
3
4
5
6
34
5
6
a
Hb
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Ethyl (R,R,R) 2-[(2-methyl-propane-2-sulfinylamino)-
pyridin-2-yl-methyl]-3-p-tolyl-but-3-enoate (R,R,R)-8d 
N
H
S
+
O
CO2Et
N
..
34
5
6
2
35
6
 
Obtained as colourless prisms (0.088 g, 60 %), mp 74-76 
oC after flash chromatography (EtOAc); RF; 0.40 (EtOAc); 
+ 18.9 (c 1.4); Found; C, 66.7; H, 7.40; N, 6.80; S, 
7.80 %; C
20][ Da
23H30N2O3S requires; C, 66.64; H, 7.27; N, 6.76; 
S, 7.73 %; νmax/cm-1; 3254 (NH), 3181, 3056, 2411, 2219, 
2051, 1926, 1823, 1738 (CO); δH (500 MHz, CDCl3); 8.54 
(1H, d, pyridyl-6H, J = 4.7 Hz), 7.61 (1H, td, pyridyl-4H, J 
= 1.7, 7.7 Hz), 7.42 (1H, d, pyridyl-3H, J = 7.7 Hz), 7.38 
(2H, d, Ar-3H, Ar-5H, J = 8.1 Hz), 7.15 (3H, m, Ar-2H, 
Ar-6H, pyridyl-5H), 5.59 (1H, s, =CHa), 5.51 (1H, s, 
=CHb), 4.95 (1H, t, NCH, J = 9.4 Hz), 4.40 (1H, d, NH, J 
= 9.4 Hz), 4.23 (1H, d, NCHCH, J = 9.4 Hz), 3.97 – 3.90 
(2H, m, OCH2), 1.06 (9H, s, C(CH3)3), 1.01 (3H, t, 
OCH2CH3, J = 7.3 Hz), δc (75 MHz, CDCl3); 172.1 (CO), 
160.3 (=C), 149.8 (Ar), 144.1 (Ar), 139.1 (Ar), 137.9 (Ar), 
137.0 (Ar), 129.4 (Ar), 126.7 (Ar), 123.9 (Ar), 123.2 (Ar), 
116.1 (=CH2), 63.9 (NC), 61.2 (OC), 56.7 (SC), 56.4 
(NCC), 23.0 (C(CH3)3), 21.5 (ArCH3), 14.3 (OCH2CH3); 
m/z (ES+); 415 (MH+). 
 
Ethyl (S,S,S) 3-Biphenyl-4-yl-2-[(2-methyl-propane-2-
sulfinylamino)-pyridin-2-yl-methyl]-but-3-enoate 
(S,S,S)-8e 
N
H
S+
O-
CO2Et
N
H
Hb
H
..
a
d
6
34
5
2
35
6
2'
3'
4'
5'
6'
 
Obtained as colourless prisms (0.164 g, 69 %), mp 64-67 
oC, after flash chromatography (EtOAc); RF; 0.27 (EtOAc); 
+ 32.6 (c 1.1); Found; 477.2214; C20][ Da 28H33N2O3S 
requires; 477.2206; νmax/cm-1; 3443, 3254 (NH), 3034, 
2960, 2309, 2217, 2060, 1963, 1834, 1731 (CO), 1623; δH 
(500 MHz, CDCl3); 8.53 (1H, d, pyridyl-6H, J = 4.7 Hz), 
7.62 (3H, m, ArH), 7.57 (4H, m, ArH), 7.43 (3H, m, ArH), 
7.33 (1H, t, ArH, J = 7.3 Hz), 7.14 (1H, dd, pyridyl-5H, J 
= 4.7, 10.3 Hz), 5.69 (1H, s, =CHa), 5.59 (1H, S, =CHb), 
5.00 (1H, t, NCH, J = 9.6 Hz), 4.44 (1H, d, NH, 9.6 Hz), 
4.30 (1H, d, NCHCH, J = 9.6 Hz), 3.97 (2H, m, OCH2,), 
1.07 (9H, s, C(CH3)3), 1.02 (3H, t, OCCH3, J 6.8 Hz); δc 
(75 MHz, CDCl3); 172.5 (CO), 159.3 (Ar), 149.6 (H2C=C), 
140.9 (Ar), 140.7 (Ar), 136.8 (Ar), 129.3 (Ar), 128.0 (Ar), 
127.4 (Ar), 127.3 (Ar), 127.2 (Ar), 127.2 (Ar), 124.1 (Ar), 
123.9 (Ar), 123.3 (Ar), 116.9 (=CH2), 63.9 (OC), 61.4 
(NC), 56.7 (SC), 56.4 (NCC), 23.1 (C(CH3)3, 14.6 (OCC); 
m/z (ES+); 478 (MH+). 
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Ethyl (R,R,R) 3-Biphenyl-4-yl-2-[(2-methyl-propane-2-
sulfinylamino)-pyridin-2-yl-methyl]-but-3-enoate 
(R,R,R)-8f 
N
H
S+
O-
CO2Et
N
H
..
6
34
5
2
35
6
2'
3'
4'
5'
6'
a
Hb
 
Obtained as colourless prisms (0.151 g, 62 %), mp 65-67 
oC,  after flash chromatography (EtOAc); RF; 0.27 (EtOAc); 
- 34.5 (c 0.6); Found; 477.2170; C20][ Da 28H33N2O3S 
requires; 477.2206;  νmax/cm-1; 3640, 3260 (NH), 2960, 
2443, 2340, 2163, 2060, 1936, 1834, 1728 (CO), 1623; δH 
(500 MHz, CDCl3); 8.53 (1H, d, pyridyl-6H, J = 4.7 Hz), 
7.62 (3H, m, ArH), 7.57 (4H, m, ArH), 7.43 (3H, m, ArH), 
7.33 (1H, t, ArH, J = 7.3 Hz), 7.14 (1H, dd, pyridyl-5H, J 
= 4.7, 10.3 Hz), 5.69 (1H, s, =CHa), 5.59 (1H, S, =CHb), 
5.00 (1H, t, NCH, J = 9.6 Hz), 4.44 (1H, d, NH, 9.6 Hz), 
4.30 (1H, d, NCHCH, J = 9.6 Hz), 3.97 (2H, m, OCH2,), 
1.07 (9H, s, C(CH3)3), 1.02 (3H, t, OCCH3, J 6.8 Hz); δc 
(75 MHz, CDCl3); 172.5 (CO), 159.3 (Ar), 149.6 (H2C=C), 
140.9 (Ar), 140.7 (Ar), 136.8 (Ar), 129.3 (Ar), 128.0 (Ar), 
127.4 (Ar), 127.3 (Ar), 127.2 (Ar), 127.1 (Ar), 124.1 (Ar), 
123.9 (Ar), 123.2 (Ar), 116.9 (=CH2), 63.9 (OC), 61.4 
(NC), 56.7 (SC), 56.4 (NCC), 23.1 (C(CH3)3, 14.6 (OCC); 
m/z (ES+); 478 (MH+). 
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